In addition, research from Lo et al. on metabolic rewiring of tumours found that FOXF2 may play a role in promoting the development of basal-like triple-negative breast cancers (TNBC) by negatively regulating PLA2G12A, PMVK and other tumour-suppressive metabolic genes53. The gene discussed is FOXF2; the disease is neoplasm.